Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Shiku

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 17, 1998
[Current status of cancer management. 4. Possibility for cancer immunotherapy]H Shiku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 10, 1990
[Cancer diagnosis by oncogenes]H Shiku
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|September 1, 1987
[Production of monoclonal antibodies]H Shiku
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1987
[Oncogene products as tumor markers]H Shiku
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1987
Biochemical and immunologic diagnosis of cancer. Leukemia and lymphomaH Shiku
FEBS Letters|May 3, 1993
A human T lymphotropic virus type I (HTLV-I) long terminal repeat-directed antisense c-myc construct with an Epstein-Barr virus replicon vector inhibits cell growth in a HTLV-I-transformed human T cell lineM Fujita, H Shiku
European Journal of Immunology|September 1, 1992
Preferential usage of JH2 in D-J joinings with DQ52 is determined by the primary DNA sequence and is largely dependent on recombination signal sequencesH Suzuki, H Shiku
Ryoikibetsu Shokogun Shirizu|December 16, 1998
[Diffuse small lymphocytic lymphoma]T Ohno, H Shiku
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1990
[Dot hybridization with synthetic oligonucleotide; analysis of point mutation of c-ras genes]Y Nagata, H Shiku
Seikagaku. the Journal of Japanese Biochemical Society|July 9, 1998
[Molecular biology and multifunctional aspects of nm23/NDPK]K Okada, H Shiku
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|November 17, 1998
[Current status of cancer management. 4. Possibility for cancer immunotherapy]H Shiku
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|September 10, 1990
[Cancer diagnosis by oncogenes]H Shiku
Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme|September 1, 1987
[Production of monoclonal antibodies]H Shiku
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 1, 1987
[Oncogene products as tumor markers]H Shiku
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1987
Biochemical and immunologic diagnosis of cancer. Leukemia and lymphomaH Shiku
FEBS Letters|May 3, 1993
A human T lymphotropic virus type I (HTLV-I) long terminal repeat-directed antisense c-myc construct with an Epstein-Barr virus replicon vector inhibits cell growth in a HTLV-I-transformed human T cell lineM Fujita, H Shiku
European Journal of Immunology|September 1, 1992
Preferential usage of JH2 in D-J joinings with DQ52 is determined by the primary DNA sequence and is largely dependent on recombination signal sequencesH Suzuki, H Shiku
Ryoikibetsu Shokogun Shirizu|December 16, 1998
[Diffuse small lymphocytic lymphoma]T Ohno, H Shiku
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 1, 1990
[Dot hybridization with synthetic oligonucleotide; analysis of point mutation of c-ras genes]Y Nagata, H Shiku
Seikagaku. the Journal of Japanese Biochemical Society|July 9, 1998
[Molecular biology and multifunctional aspects of nm23/NDPK]K Okada, H Shiku
Pageof 33